Evidence map›Paper›PMID 39547236›Full record

ArticleCell chemical biology2024

Chemical tools to expand the ligandable proteome: Diversity-oriented synthesis-based photoreactive stereoprobes.

Daisuke Ogasawara, David B Konrad, Zher Yin Tan, Kimberly L Carey, Jessica Luo, Sang Joon Won, Haoxin Li, Trever R Carter, Kristen E DeMeester, Evert Njomen and 4 more

Abstract read
In one paragraph

Article in Cell chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Integrated phenotypic screening and chemical proteomics identifies ETF1 ligands that modulate viral translation and replication.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Daisuke OgasawaraDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address: daisuke@scripps.edu.
David B KonradDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA.
Zher Yin TanImmunology Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, MA 02142, USA; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Kimberly L CareyImmunology Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Jessica LuoImmunology Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Sang Joon WonDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA.
Haoxin LiDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA.
Trever R CarterDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA.
Kristen E DeMeesterDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA.
Evert NjomenDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA.
Stuart L SchreiberChemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, MA 02142, USA; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Ramnik J XavierImmunology Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Center for Computational and Integrative Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Bruno MelilloDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address: bmelillo@scripps.edu.
Benjamin F CravattDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address: cravatt@scripps.edu.

Funding

RP5: Chemical proteomic discovery of small-molecule probes for autophagy proteinsU19AI142784 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI CRAVATT, BENJAMIN F · 2019 to 2023
$36.9M
Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Chemical Proteomic Platforms for Radically Expanding Cancer DruggabilityR35CA231991 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI BENJAMIN F CRAVATT · 2018 to 2026
$9.5M
Integrated ligand and target discovery by chemical proteomics for glioblastoma treatment.R01CA238249 · NCI · STANFORD UNIVERSITY · PI CRAVATT, BENJAMIN F, MISCHEL, PAUL S · 2021 to 2025
$3.3M
NCI NIH HHS R01 CA238249NCI NIH HHS R35 CA231991NIAID NIH HHS U19 AI142784NIDDK NIH HHS P30 DK043351
6 · The paper itself

Abstract

Chemical proteomics enables the global analysis of small molecule-protein interactions in native biological systems and has emerged as a versatile approach for ligand discovery. The range of small molecules explored by chemical proteomics has, however, remained limited. Here, we describe a diversity-oriented synthesis (DOS)-inspired library of stereochemically defined compounds bearing diazirine and alkyne units for UV light-induced covalent modification and click chemistry enrichment of interacting proteins, respectively. We find that these "photo-stereoprobes" interact in a stereoselective manner with hundreds of proteins from various structural and functional classes in human cells and demonstrate that these interactions can form the basis for high-throughput screening-compatible NanoBRET assays. Integrated phenotypic screening and chemical proteomics identified photo-stereoprobes that modulate autophagy by engaging the mitochondrial serine protease CLPP. Our findings show the utility of DOS-inspired photo-stereoprobes for expanding the ligandable proteome, furnishing target engagement assays, and facilitating the discovery and characterization of bioactive compounds in phenotypic screens.

Indexed as

ProteomeUltraviolet RaysAlkynesClick ChemistryDiazomethaneHigh-Throughput Screening AssaysHumansLigandsMolecular StructureProteomicsSmall Molecule LibrariesStereoisomerismAlkynesDiazomethaneLigandsProteomeSmall Molecule Librariesautophagychemical proteomicsdiazirinediversity-oriented synthesisligandsNanoBRETphenotypic screeningphotoreactiveprobesproteomicsstereochemistry

Identifiers

PMID39547236
PMCPMC11837778

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.